-+ 0.00%
-+ 0.00%
-+ 0.00%

Rocket Lab (RKLB) Marks Its 94th Electron Launch, Is The Pullback A Valuation Opportunity?

Simply Wall St·09/03/2026 20:20:13
Listen to the news

Rocket Lab (RKLB) just completed its 94th Electron mission, placing Synspective’s latest StriX Earth imaging satellite into low Earth orbit and reinforcing confidence in its launch and satellite services capabilities.

For investors, Rocket Lab’s latest launch comes after a sharp reset in the share price. The stock is down 10.4% on a 30 day share price return and 47.4% on a 90 day share price return, even though the 1 year total shareholder return is 45% and the 3 year total shareholder return is almost 9x.

Scan 36 robotics and automation stocks that echo Rocket Lab’s mix of launch hardware, satellites, and automation so you can compare this mission-driven story with other high-tech space and robotics plays.

Rocket Lab now trades well below both intrinsic value estimates and analyst targets after that sharp pullback. Is this a reasonable discount for execution and capital risk, or has caution swung too far and mispriced the story ahead of a valuation check?

Most Popular Narrative: 25.8% Undervalued

At a last close of $63.10, the most followed Rocket Lab valuation narrative points to a fair value of $85.04, which frames the recent share price reset as a discount to that story.

Rocket Lab is mid transformation from a small launch specialist into a vertically integrated space and defense prime, with Space Systems now ~67% of revenue and growing fastest.

A $1.85B backlog (+73% YoY) anchored by the $816M SDA Tranche 3 award provides multi-year revenue visibility that the current trailing P/S of ~72x does not yet fully reflect.

Read the complete narrative. Read the complete narrative.

The fair value hinges on a specific revenue ramp, margin lift from vertical integration, and expectations around Neutron and defense contracts. Curious which projections sit behind that $85.04 figure and how they connect to today’s $63.10 price gap?

Result: Fair Value of $85.04 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, Rocket Lab’s story still hinges on Neutron hitting its milestones and on a concentrated defense backlog, so any launch slip or contract disruption could quickly challenge this 25.8% undervalued narrative.

Find out about the key risks to this Rocket Lab narrative.

Another View on Rocket Lab’s Valuation

While the leading Rocket Lab narrative points to a 25.8% discount to fair value, the picture looks very different when using the P/S ratio. RKLB trades on a P/S of 49.1x, versus a fair ratio of 11x and a US Aerospace & Defense average of 4.2x and peer average of 7.4x. That gap suggests investors are paying a high premium today. The key question is whether you are comfortable tying your thesis to that kind of multiple risk.

See what the numbers say about this price, See what the numbers say about this price — find out in our valuation breakdown.

NasdaqGS:RKLB P/S Ratio as at Sep 2026
NasdaqGS:RKLB P/S Ratio as at Sep 2026

Next Steps

With Rocket Lab’s mixed signals on value and risk, it makes sense to look at the full picture quickly and frame your own stance using 2 key rewards and 3 important warning signs.

Looking for more investment ideas beyond Rocket Lab?

If Rocket Lab has sharpened your focus on high conviction opportunities, do not stop here. The right screener can quickly surface ideas that match your style.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.